Additionally, considering significant function of PD‐1 in regulating the immune response of activated T cells, targeting PD‐1/PD‐L1 pathway may impede tumour immune evasion, but may also potentially disrupt the balance between normal tissues and cancer cells, resulting in immune imbalance.23, 26. The gene discussed is CD274; the disease is cancer.